Region: United States

Harness Advanced Genomics to Personalize Breast Cancer Care

The Oncotype DX® family of breast cancer tests provide a thorough view of each patient’s unique tumor.

Every patient is different. That means every tumor is different. With the genomic-based insights of Oncotype DX tests, you can make informed decisions with actionable data customized to each patient’s situation.

Oncotype DX Breast Cancer test

The intelligent test for early-stage breast cancers

Oncotype DX Breast Recurrence Score

The only genomic test proven to predict a patient’s individual benefit from chemotherapy

For patients with early-stage (I, II, or IIIa), HR (hormone receptor)-positive, HER2-negative breast cancer that is either node-negative or node-positive (1-3 nodes)

Explore test
Oncotype DX Breast DCIS Score

The only genomic test to quantify the risk of local recurrence (DCIS or invasive) in ductal carcinoma in situ.

For patients with ductal carcinoma in situ (DCIS) treated by local excision, with or without tamoxifen.

EXPLORE TEST

Order a Test

Tests are available through our Provider Hub. Simply request a specimen kit to submit a sample by calling +1 866-ONCOTYPE (+1 866-662-6897) prior to completing a requisition form on the Provider Hub. Once you order, we then work with the pathology team or treating physician to obtain the sample using the specimen kit.

How to order the Oncotype DX Breast Recurrence Score® test
Order through provider hub
Sign up for the Provider Hub

Have questions?

+1 866-662-6897

Email Customer Service

Contact Us